Procter & Gamble Health · NSE: PGHL · BSE: 500126
Q4 FY19 results · Jan–Mar 2019
Procter & Gamble Health reported revenue from operations of ₹231.03 crore and net profit of ₹40.71 crore for Q4 FY19 (Jan–Mar 2019), on a standalone basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 231.03 | — | — | 204.39 | +13.0% |
| Other income | 17.69 | — | — | 7.17 | +146.6% |
| Total income | 248.72 | — | — | 211.57 | +17.6% |
| Profit before tax | 63.49 | — | — | 17.89 | +254.9% |
| Net profit for the period | 40.71 | — | — | 715.34 | −94.3% |
| EPS, basic (₹) | 24.52 | — | — | 430.94 | −94.3% |
| Net margin (%) | 17.6 | — | 350.0 |
Standalone
- Filed with BSE
- 11 May 2019, 14:25 IST
- Board meeting
- 10 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE